← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
Ginkgo biloba tinnitus study cluster
Also known as: Ginkgo Biloba Extract, EGb 761, Ginkgo biloba tinnitus studies
Institution-led study cluster
Sponsor / Institution
Institution-led study cluster
Program Type
Therapeutic
Modality
Small Molecule
Stage
Not applicable
Status
Completed
Target Gene
—
Route / Mode
Oral
Confidence
86%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
China, Czech Republic
Population
adult, tinnitus
Trial IDs
3
Mechanism
Mixed academic tinnitus study cluster where ginkgo biloba extract was used as adjunct/comparator in acute tinnitus prednisone studies and as medication comparator in a chronic tinnitus rTMS trial.
Indications
Notes
Registry-verified mixed ginkgo biloba tinnitus study cluster. It should not be shown as a unified company-sponsored pipeline product; it is a generic study intervention/comparator across academic trials.
Evidence & Sources
3 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT06124703
clinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT05591144
clinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT03425045
Key Events
Clinical Trials (3)
Data Checks
institution-led-study-clusterregistry-only-evidencegeneric-drug-study-clustermixed-study-statusesnot-confirmed-current-product
Related Programs
Otarmeni by Regeneron
Company: Regeneron Pharmaceuticals · Gene Therapy · Approved
PEDMARK by Fennec Pharmaceuticals
Company: Fennec Pharmaceuticals · Small Molecule · Marketed
AK-OTOF by Eli Lilly and Akouos
Company: Eli Lilly and Company · Gene Therapy · Phase 2
SENS-401 (Arazasetron) by Sensorion
Company: Sensorion · Small Molecule · Phase 2
SENS-501 by Sensorion
Company: Sensorion · Gene Therapy · Phase 1/2
Rincell-1 by Rinri Therapeutics
Company: Rinri Therapeutics · Cell Therapy · Phase 1/2